The MDRD equation underestimates the prevalence of CKD among blacks and overestimates the prevalence of CKD among whites compared to the CKD-EPI equation: A retrospective cohort study

BMC Nephrology

Volumn 13, Issue 1, 2012, Pages

  Arora, Pradeep ^a,b   Rajagopalan, Srini ^c   Patel, Nilang ^b   Nainani, Neha ^b   Venuto, Rocco C ^b   Lohr, James W ^a,b  

^a VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c Med Data Analytics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CAUCASIAN; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY DISEASE EPIDEMIOLOGY COLLABORATION EQUATION; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL PARAMETERS; MODIFICATION OF DIET IN RENAL DISEASE EQUATION; NEGRO; PREVALENCE; RETROSPECTIVE STUDY; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; ETHNOLOGY; HOSPITALIZATION; MIDDLE AGED; PATHOPHYSIOLOGY; STATISTICS; VETERAN;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; VETERANS; YOUNG ADULT;

EID: 84856020204     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-13-4     Document Type: Article

References (30)

1. Prevalence of chronic kidney disease in the United States. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS, JAMA 2007 298 17 2038 2047 10.1001/jama.298.17.2038 17986697 (Pubitemid 350074801)
2. USRDS 2009: Annual Report: Atlas of Chronic Kidney Disease and End Stage Renal Disease in the United States, Bethesda, MD. United States Renal Data System, National Institutes of Health. National Institute of Diabetes and Digestive and Kidney Diseases 2009
3. Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study. McClellan W, Warnock DG, McClure L, Campbell RC, Newsome BB, Howard V, Cushman M, Howard G, J Am Soc Nephrol 2006 17 6 1710 1715 10.1681/ASN.2005111200 16641151 (Pubitemid 43794674)
4. Longitudinal study of racial and ethnic differences in developing end-stage renal disease among aged medicare beneficiaries. Xue JL, Eggers PW, Agodoa LY, Foley RN, Collins AJ, J Am Soc Nephrol 2007 18 4 1299 1306 10.1681/ASN.2006050524 17329578 (Pubitemid 46536916)
5. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS, Am J Kidney Dis 2003 41 1 1 12 12500213 (Pubitemid 36043346)
6. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002 39 2 Suppl 1 1 266 11904577
7. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG, Ann Intern Med 2004 141 12 929 937 15611490
8. Evaluation of the modification of diet in renal disease study equation in a large diverse population. Stevens LA, Coresh J, Feldman HI, Greene T, Lash JP, Nelson RG, Rahman M, Deysher AE, Zhang YL, Schmid CH, et al. J Am Soc Nephrol 2007 18 10 2749 2757 10.1681/ASN.2007020199 17855641 (Pubitemid 47531202)
9. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F, Ann Intern Med 2006 145 4 247 254 16908915 (Pubitemid 46768608)
10. A new equation to estimate glomerular filtration rate. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al. Ann Intern Med 2009 150 9 604 612 19414839
11. Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation camopared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) study. Matsushita K, Selvin E, Bash LD, Astor BC, Coresh J, Am J Kidney Dis 2010 55 648 659 10.1053/j.ajkd.2009.12. 016 20189275
12. National Institute for Health and Clinical Excellence Guideline C673. Chronic kidney Disease 2008
13. Racial and ethnic differences in preventable hospitalizations across 10 states. Gaskin DJ, Hoffman C, Med Care Res Rev 2000 57 Suppl 1 85 107 11092159
14. White/black racial differences in risk of end-stage renal disease and death. Choi AI, Rodriguez RA, Bacchetti P, Bertenthal D, Hernandez GT, O'Hare AM, Am J Med 2009 122 7 672 678 10.1016/j.amjmed.2008.11.021 19559170
15. Racial differences in the incidence of treatment for end-stage renal disease. Rostand SG, Kirk KA, Rutsky EA, Pate BA, N Engl J Med 1982 306 21 1276 1279 10.1056/NEJM198205273062106 7040967 (Pubitemid 12100210)
16. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, Ann Intern Med 1999 130 6 461 470 10075613 (Pubitemid 29135798)
17. Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III). Clase CM, Garg AX, Kiberd BA, J Am Soc Nephrol 2002 13 5 1338 1349 10.1097/01.ASN. 0000013291.78621.26 11961022 (Pubitemid 34441415)
18. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Hunsicker LG, Adler S, Caggiula A, England BK, Greene T, Kusek JW, Rogers NL, Teschan PE, Kidney Int 1997 51 6 1908 1919 10.1038/ki.1997.260 9186882 (Pubitemid 27252762)
19. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. Hsu CY, Lin F, Vittinghoff E, Shlipak MG, J Am Soc Nephrol 2003 14 11 2902 2907 10.1097/01.ASN.0000091586. 46532.B4 14569100 (Pubitemid 37305653)
20. The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors. Brancati FL, Whittle JC, Whelton PK, Seidler AJ, Klag MJ, JAMA 1992 268 21 3079 3084 10.1001/jama.1992.03490210061036 1433738
21. Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors. Tarver-Carr ME, Powe NR, Eberhardt MS, LaVeist TA, Kington RS, Coresh J, Brancati FL, J Am Soc Nephrol 2002 13 9 2363 2370 10.1097/01.ASN.0000026493.18542.6A 12191981 (Pubitemid 34925247)
22. The epidemiology of end-stage renal disease among African Americans. Martins D, Tareen N, Norris KC, Am J Med Sci 2002 323 2 65 71 10.1097/00000441-200202000-00002 11863081 (Pubitemid 34651556)
23. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, Bowden DW, Oleksyk T, McKenzie LM, Kajiyama H, Ahuja TS, et al. Nat Genet 2008 40 10 1175 1184 10.1038/ng.226 18794856
24. Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage. Suthanthiran M, Li B, Song JO, Ding R, Sharma VK, Schwartz JE, August P, Proc Natl Acad Sci USA 2000 97 7 3479 3484 10.1073/pnas.050420897 10725360 (Pubitemid 30183328)
25. Racial differences in mortality and ESRD. Norris K, Mehrotra R, Nissenson AR, Am J Kidney Dis 2008 52 2 205 208 10.1053/j.ajkd.2008.06.004 18640483 (Pubitemid 351978152)
26. Survival advantage of black patients with kidney disease after acute myocardial infarction. Newsome BB, McClellan WM, Coffey CS, Allison JJ, Kiefe CI, Warnock DG, Clin J Am Soc Nephrol 2006 1 5 993 999 10.2215/CJN.01251005 17699318
27. Racial differences in mortality among those with CKD. Mehrotra R, Kermah D, Fried L, Adler S, Norris K, J Am Soc Nephrol 2008 19 7 1403 1410 10.1681/ASN.2007070747 18385428
28. Differences in mortality and use of revascularization in black and white patients with acute MI admitted to hospitals with and without revascularization services. Popescu I, Vaughan-Sarrazin MS, Rosenthal GE, JAMA 2007 297 22 2489 2495 10.1001/jama.297.22.2489 17565083 (Pubitemid 46953402)
29. Assessment of racial disparities in chronic kidney disease stage 3 and 4 care in the department of defense health system. Gao SW, Oliver DK, Das N, Hurst FP, Lentine KL, Agodoa LY, Sawyers ES, Abbott KC, Clin J Am Soc Nephrol 2008 3 2 442 449 10.2215/CJN.03940907 18199843
30. MDRD or CKD-EPI study equations for estimating prevalence of stage 3 CKD in epidemiological studies: which difference? Is this difference relevant? Delanaye P, Cavalier E, Mariat C, Maillard N, Krzesinski JM, BMC Nephrol 2010 11 8 10.1186/1471-2369-11-8 20515483